Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis
Eun Ran Kim and Dong Kyung Chang
Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorectal cancer (CRC), although the overall incidence of IBD-associated CRC has been diminishing in recent decades in western countries. As demonstrated in previous studies, the risk of CRC in IBD increases with longer duration, extent of colitis, a familial history of CRC, coexistent primary sclerosing cholangitis, and the degree of inflammation. The pathogenesis of CRC in IBD is poorly understood ... Please click here to read the full article.
World J Gastroenterol. 2014 August 7; 20(29): 9872-9881.
Published online 2014 August 7. doi: 10.3748/wjg.v20.i29.9872.
Eun Ran Kim and Dong Kyung Chang
Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorectal cancer (CRC), although the overall incidence of IBD-associated CRC has been diminishing in recent decades in western countries. As demonstrated in previous studies, the risk of CRC in IBD increases with longer duration, extent of colitis, a familial history of CRC, coexistent primary sclerosing cholangitis, and the degree of inflammation. The pathogenesis of CRC in IBD is poorly understood ... Please click here to read the full article.
World J Gastroenterol. 2014 August 7; 20(29): 9872-9881.
Published online 2014 August 7. doi: 10.3748/wjg.v20.i29.9872.
RSS Feed